| pubmed-article:19333801 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0002736 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0025936 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0007806 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0162597 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0376152 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:19333801 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
| pubmed-article:19333801 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19333801 | pubmed:dateCreated | 2009-4-29 | lld:pubmed |
| pubmed-article:19333801 | pubmed:abstractText | The blood-brain barrier (BBB) is the main obstacle to cell therapy for neurologic disorders such as amyotrophic lateral sclerosis (ALS). Intrathecal injection is a potential method for cell transplantation because it would bypass the BBB. We investigated the effects of human marrow stromal cells (hMSC) delivered through cerebrospinal fluid (CSF) in a transgenic mouse model of ALS. | lld:pubmed |
| pubmed-article:19333801 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19333801 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19333801 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19333801 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19333801 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19333801 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19333801 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19333801 | pubmed:issn | 1477-2566 | lld:pubmed |
| pubmed-article:19333801 | pubmed:author | pubmed-author:ZhangChenC | lld:pubmed |
| pubmed-article:19333801 | pubmed:author | pubmed-author:ZhangChengC | lld:pubmed |
| pubmed-article:19333801 | pubmed:author | pubmed-author:ZhouChangC | lld:pubmed |
| pubmed-article:19333801 | pubmed:author | pubmed-author:TengJi-JunJJ | lld:pubmed |
| pubmed-article:19333801 | pubmed:author | pubmed-author:ZhaoRen-Liang... | lld:pubmed |
| pubmed-article:19333801 | pubmed:author | pubmed-author:SongYu-QiangY... | lld:pubmed |
| pubmed-article:19333801 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19333801 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:19333801 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19333801 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19333801 | pubmed:pagination | 299-306 | lld:pubmed |
| pubmed-article:19333801 | pubmed:dateRevised | 2010-1-11 | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:meshHeading | pubmed-meshheading:19333801... | lld:pubmed |
| pubmed-article:19333801 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19333801 | pubmed:articleTitle | Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis. | lld:pubmed |
| pubmed-article:19333801 | pubmed:affiliation | Department of Neurology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, [corrected] PR China. chengzhang100@hotmail.com | lld:pubmed |
| pubmed-article:19333801 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19333801 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
